Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Gender, racial disparities persist in statin use by ASCVD patients

Key clinical point: Gender and racial gaps in statin prescriptions for patients with atherosclerotic cardiovascular disease.

Major finding: Between 2008 and 2017, the annual percentage change in statin use was 0.25% among men versus 0.14% in women (P = .022).

Study details: An analysis of data on 15,911 patients contained in the 2008-2017 Medical Expenditure Panel Survey.

Disclosures: Dr. Salami reported having no disclosures.

Citation:

Salami A et al. Epi/Lifestyle 2020, Abstract 4.